SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.
Medical Devices
Synchron’s BCI meets primary endpoint in feasibility trial
Wesper sleep platform reduces nerve stimulation titration time by 45%
Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant
Synergia implants first patients with neurostimulator for epilepsy treatment
Onward implants second patient with brain chip in spinal cord injury trial
Medtronic teases positive data adaptive deep brain stimulation trial
Koya’s NPCD device proves more effective than APCDs in lymphedema
